https://www.selleckchem.com/pr....oducts/picropodophyl
6% (130/195) and treatment success rate of single-dose MTX was comparable between the obese and non-obese groups (64.5% vs. 67.0%, p = 0.78). Obese patients were older as compared to non-obese (median age 33 vs. 29, p = 0.03). In multivariate logistic regression analysis, percentage hCG change from day 1 to day 4 was the only factor associated with treatment success (aOR 1.02; 95%CI 1.01, 1.04, p less then 0.001). Conclusion Single-dose MTX treatment among obese patients diagnosed with ectopic pregnancy led to similar succe
Like
Comment
Share
